98 related articles for article (PubMed ID: 21824785)
1. The role of IL-21 in hematological malignancies.
Ma J; Ma D; Ji C
Cytokine; 2011 Nov; 56(2):133-9. PubMed ID: 21824785
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 signaling: functions in cancer and autoimmunity.
Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24.
Gopalkrishnan RV; Sauane M; Fisher PB
Int Immunopharmacol; 2004 May; 4(5):635-47. PubMed ID: 15120649
[TBL] [Abstract][Full Text] [Related]
4. Biology of IL-21 and the IL-21 receptor.
Mehta DS; Wurster AL; Grusby MJ
Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
6. Immune modulation with interleukin-21.
Bhave NS; Carson WE
Ann N Y Acad Sci; 2009 Dec; 1182():39-46. PubMed ID: 20074273
[TBL] [Abstract][Full Text] [Related]
7. mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo.
Dong CY; Zhang F; Duan YJ; Yang BX; Lin YM; Ma XT
Exp Hematol; 2008 Aug; 36(8):938-46. PubMed ID: 18468766
[TBL] [Abstract][Full Text] [Related]
8. New insights of common gamma chain in hematological malignancies.
Goh TS; Hong C
Cytokine; 2017 Jan; 89():179-184. PubMed ID: 26748725
[TBL] [Abstract][Full Text] [Related]
9. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory and antitumor effects of interleukin-21 in patients with renal cell carcinoma.
Curti BD
Expert Rev Anticancer Ther; 2006 Jun; 6(6):905-9. PubMed ID: 16761934
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 21 - its potential role in the therapy of B-cell lymphomas.
Bhatt S; Sarosiek KA; Lossos IS
Leuk Lymphoma; 2017 Jan; 58(1):17-29. PubMed ID: 27405876
[TBL] [Abstract][Full Text] [Related]
12. MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
Chada S; Sutton RB; Ekmekcioglu S; Ellerhorst J; Mumm JB; Leitner WW; Yang HY; Sahin AA; Hunt KK; Fuson KL; Poìndexter N; Roth JA; Ramesh R; Grimm EA; Mhashilkar AM
Int Immunopharmacol; 2004 May; 4(5):649-67. PubMed ID: 15120650
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
Parrish-Novak J; Foster DC; Holly RD; Clegg CH
J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-21: a new modulator of immunity, infection, and cancer.
Brandt K; Singh PB; Bulfone-Paus S; Rückert R
Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
[TBL] [Abstract][Full Text] [Related]
15. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
16. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.
Barata JT; Keenan TD; Silva A; Nadler LM; Boussiotis VA; Cardoso AA
Haematologica; 2004 Dec; 89(12):1459-67. PubMed ID: 15590396
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
Strengell M; Julkunen I; Matikainen S
J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
[TBL] [Abstract][Full Text] [Related]
20. Role of IL-21 in inflammatory bowel disease.
Pallone F; Fina D; Caruso R; Monteleone G
Expert Rev Clin Immunol; 2010 Jul; 6(4):537-41. PubMed ID: 20594126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
